Being tested
Cell therapy or transplant: slow disability worsening in MS (type not specified)
MS (type not specified) · Cell therapy or transplant
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 3
- Running now
- 2
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
Phase 2 results not all read yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Cell or transplant, phase 2 | Phase 2 | 110 | 2005 | No results found | Counts only if it beats dimethyl fumarate, fingolimod, natalizumab |
| Stem cell transplantation, trial | Not a drug-phase study | 20 | 2026 | Still running | Not counted: not randomised |
| CONTRASTOME | Not a drug-phase study | 60 | 2025 | Still running | Not counted: not randomised |
Counted: 0. Will count later: 1. Not counted: 2.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
Assembled by software from public sources.